tiprankstipranks
Trending News
More News >
Abattis Bioceuticals Corp (ATTBF)
OTHER OTC:ATTBF
US Market

Abattis Bioceuticals (ATTBF) Ratios

Compare
175 Followers

Abattis Bioceuticals Ratios

ATTBF's free cash flow for Q4 2019 was C$0.72. For the 2019 fiscal year, ATTBF's free cash flow was decreased by C$ and operating cash flow was C$-3.93. See a summary of the company’s cash flow.
Ratios
TTM
Dec 19Dec 18Dec 17Dec 16
Liquidity Ratios
Current Ratio
0.73---
Quick Ratio
0.68---
Cash Ratio
0.41---
Solvency Ratio
-0.34---
Operating Cash Flow Ratio
1.92---
Short-Term Operating Cash Flow Coverage
6.64---
Net Current Asset Value
C$ -4.99M---
Leverage Ratios
Debt-to-Assets Ratio
0.08---
Debt-to-Equity Ratio
0.14---
Debt-to-Capital Ratio
0.12---
Long-Term Debt-to-Capital Ratio
0.00---
Financial Leverage Ratio
1.74---
Debt Service Coverage Ratio
-2.62---
Interest Coverage Ratio
-80.16---
Debt to Market Cap
70.54---
Interest Debt Per Share
<0.01---
Net Debt to EBITDA
0.12---
Profitability Margins
Gross Profit Margin
67.62%---
EBIT Margin
-843.89%---
EBITDA Margin
-1078.19%---
Operating Profit Margin
-1108.73%---
Pretax Profit Margin
-857.72%---
Net Profit Margin
-852.40%---
Continuous Operations Profit Margin
-857.72%---
Net Income Per EBT
99.38%---
EBT Per EBIT
77.36%---
Return on Assets (ROA)
-15.79%---
Return on Equity (ROE)
-26.96%---
Return on Capital Employed (ROCE)
-27.58%---
Return on Invested Capital (ROIC)
-25.05%---
Return on Tangible Assets
-68.98%---
Earnings Yield
-15358.89%---
Efficiency Ratios
Receivables Turnover
2.30---
Payables Turnover
0.53---
Inventory Turnover
0.43---
Fixed Asset Turnover
0.47---
Asset Turnover
0.02---
Working Capital Turnover Ratio
0.08---
Cash Conversion Cycle
310.19---
Days of Sales Outstanding
158.61---
Days of Inventory Outstanding
846.07---
Days of Payables Outstanding
694.49---
Operating Cycle
1.00K---
Cash Flow Ratios
Operating Cash Flow Per Share
0.02---
Free Cash Flow Per Share
<0.01---
CapEx Per Share
0.01---
Free Cash Flow to Operating Cash Flow
0.46---
Dividend Paid and CapEx Coverage Ratio
1.86---
Capital Expenditure Coverage Ratio
1.86---
Operating Cash Flow Coverage Ratio
6.00---
Operating Cash Flow to Sales Ratio
26.37---
Free Cash Flow Yield
21633.37%---
Valuation Ratios
Price-to-Earnings (P/E) Ratio
>-0.01---
Price-to-Sales (P/S) Ratio
0.06---
Price-to-Book (P/B) Ratio
<0.01---
Price-to-Free Cash Flow (P/FCF) Ratio
<0.01---
Price-to-Operating Cash Flow Ratio
<0.01---
Price-to-Earnings Growth (PEG) Ratio
>-0.01---
Price-to-Fair Value
<0.01---
Enterprise Value Multiple
0.11---
Enterprise Value
-429.73K---
EV to EBITDA
0.11---
EV to Sales
-1.20---
EV to Free Cash Flow
-0.10---
EV to Operating Cash Flow
-0.05---
Tangible Book Value Per Share
>-0.01---
Shareholders’ Equity Per Share
0.02---
Tax and Other Ratios
Effective Tax Rate
0.00---
Revenue Per Share
<0.01---
Net Income Per Share
>-0.01---
Tax Burden
0.99---
Interest Burden
1.02---
Research & Development to Revenue
0.00---
SG&A to Revenue
8.34---
Stock-Based Compensation to Revenue
<0.01---
Income Quality
-3.07---
Currency in CAD